These findings suggest that Gal-1 mediates radioresistance through the H-Ras-dependent pathway involved in DNA damage repair and targeting Gal-1 may improve the local control of cervical cancer (Table 2). The gene discussed is LGALS1; the disease is cervical carcinoma.